Denise Pollard-Knight Insider Profile
4 Followers
Denise Pollard-Knight, Director at Elanco Animal Health, holds 105.59K shares in Elanco Animal Health (Ticker: ELAN), holds 808.92K shares in Mereo Biopharma Group Plc (Ticker: MREO), holds 1.17M shares in Albireo Pharma (Ticker: ALBO).
Denise Pollard-Knight Elanco Animal Health (ELAN)Director
Elanco Animal Health (ELAN)
Director
Ranked #50,676 out of 109,106 Corporate Insiders
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
+0.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Denise Pollard-Knight holds in companies
Most Profitable Insider Trade
Stock:
OncoMed Pharma
(OMED)
(OMED)
Rating:Informative Sell
Date:Jul 02, 2014 - Jul 02, 2015
Return:+10.70%
The most profitable trade made by Denise Pollard-Knight
Denise Pollard-Knight's Trading History
Elanco Animal Health
May 26, 2026
Director
Uninformative Buy
―
$2.36M
Mereo Biopharma Group Plc
Sep 16, 2024
CEO, Director
Uninformative Sell
381.29K
$299.30K
OncoMed Pharma
Jan 05, 2015
―
Informative Sell
82.29K
$1.73M
Albireo Pharma
Nov 07, 2016
―
Uninformative Buy
―
$51.45M
Idenix Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Denise Pollard-Knight's performance on stock
You May Also Like
Denise Pollard-Knight insider profile FAQ
What is the percentage of profitable transactions made by Denise Pollard-Knight?
The percentage of profitable transactions made by Denise Pollard-Knight is 50%.
What is the average return per transaction made by Denise Pollard-Knight?
The average return per transaction made by Denise Pollard-Knight is 0.40%.
What stocks does Denise Pollard-Knight hold?
Denise Pollard-Knight holds: ELAN, MREO, OMED, ALBO, IDIX stocks.
What was Denise Pollard-Knight’s latest transaction?
Denise Pollard-Knight latest transaction was an Uninformative Buy of ―.
What was Denise Pollard-Knight's most profitable transaction?
Denise Pollard-Knight’s most profitable transaction was an Informative Sell of OMED stock on July 2, 2014. The return on the trade was 10.70%.
What is Denise Pollard-Knight's role in Elanco Animal Health?
Denise Pollard-Knight's role in Elanco Animal Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.